We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current CLBT market cap is 4.53B. The company's latest EPS is USD -0.3950 and P/E is -13.29.
| Quarter End | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 76.68M | 84.18M | 89.58M | 95.71M | 106.86M |
| Operating Income | 4.62M | 13.48M | 9.25M | 12.49M | 19.45M |
| Net Income | -32.35M | 6.5M | -71.37M | -23.81M | -207.09M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 171.85M | 194.91M | 246.25M | 270.65M | 325.11M |
| Operating Income | -1.52M | 9.22M | 13.82M | 1.04M | 33.24M |
| Net Income | -10.04M | -9.34M | 70.43M | 120.81M | -81.1M |
| Quarter End | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 425.89M | 476.94M | 529.14M | 556.58M | 629.25M |
| Total Liabilities | 408.34M | 439M | 555.84M | 596.74M | 330.93M |
| Total Equity | 17.56M | 37.94M | -26.71M | -40.16M | 298.32M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 280.24M | 364.39M | 339.78M | 403.29M | 532.89M |
| Total Liabilities | 120.21M | 199.38M | 413.13M | 329.43M | 498.67M |
| Total Equity | 58.83M | 63.8M | -73.35M | 73.87M | 34.21M |
| Quarter End | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 16.58M | 29.18M | 10.04M | 14.51M | 41.65M |
| Investing | -10.74M | -10.9M | -81.6M | -33.26M | -18.67M |
| Financing | 5.69M | 8.82M | 5.07M | 3.32M | 5.53M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 16.13M | 66.51M | 36.05M | 20.58M | 102.06M |
| Investing | -46.72M | -6.45M | 45.23M | -91.23M | -22.54M |
| Financing | 75.54M | -8.59M | -68.4M | 13.97M | 21.77M |
| Market Cap | 4.53B |
| Price to Earnings Ratio | -13.29 |
| Price to Sales Ratio | 3.32 |
| Price to Cash Ratio | 5.69 |
| Price to Book Ratio | 31.5 |
| Dividend Yield | - |
| Shares Outstanding | 205.3M |
| Average Volume (1 week) | 655.58k |
| Average Volume (1 Month) | 961.25k |
| 52 Week Change | 157.23% |
| 52 Week High | 22.91 |
| 52 Week Low | 7.91 |
| Spread (Intraday) | 0.29 (1.32%) |
| Company Name | Cellebrite Digital Intelligence Ltd |
| Address |
94 shlomo shmelzer road petah tikva, center 4970602 |
| Website | https://www.cellebrite.com |
| Industry | prepackaged software (7372) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
